Cancer Monoclonal Antibodies Market By Application (Liver, Breast, Blood, Brain, Hodgkin’s And Non-Hodgkin’s Lymphoma, Colorectal, Leukaemia And Others) By Type (murine Antibodies, Chimeric And Humanised Antibodies And Fully Humanized Antibodies) By Conjugated Cancer Therapies And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Cancer Monoclonal Antibodies Market By Application (Liver, Breast, Blood, Brain, Hodgkin’s And Non-Hodgkin’s Lymphoma, Colorectal, Leukaemia And Others) By Type (murine Antibodies, Chimeric And Humanised Antibodies And Fully Humanized Antibodies) By Conjugated Cancer Therapies And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

ID: 185 | Pages: 173 | October 2018 | Region: Global


Overview of the Market:
According to the Global Cancer Monoclonal Antibodies Market Research Report, the market was currently estimated to be at a USD 37.13 billion in 2018 and is poised to reach USD 63.13 billion by the end of 2023 with a CAGR of 11.2% from 2018-2023.

Cancer is a severe diseases causing millions of death worldwide every year. Cancer starts from a single cell and genetically transforms a normal cell into tumor cell and is gradually spread to other cells. With the dramatic increase in the number of people affected by cancer, many pharmaceutical players started to invest in monoclonal antibodies. While the drugs are used for the treatment of cancer, drugs like chemotherapy agents have adverse side effects as they affect the normal cells as well along with cancerous cells. This prompted the increased usage of Monoclonal Antibodies for the treatment of cancer.

Monoclonal Antibodies having the potential to offer less toxic and efficient therapeutic alternatives to the patients have been emerging in the recent years. Monoclonal Antibodies are used to treat a wide array of diseases related to autoimmune, inflammatory and especially cancer. Monoclonal Antibodies (mAbs) are mono-specific antibodies bodies comprising of identical immune cells that are clones of a single parent cell and are directed to specific cellular targets. Thus Monoclonal Antibodies are highly customizable due to its specific nature and can play a crucial role in eliminating the cancerous cell while sparing the normal cells during the cancer treatment.  The monoclonal antibodies are proved to be more effective than chemotherapies and drugs for cancer treatment.

The dramatic increase in the number of cancer patients has led many pharmaceutical players to invest in monoclonal antibodies market. Increasing investment in research and development of genomic studies, technological advancements in genetic sequencing and target gene selection, specificity of monoclonal antibodies to target only the cancer cells with no side effects are the some of the driving forces of the market. Increased prevalence of cancer is the key driver for the monoclonal antibodies market, it is expected to grow lucratively in the next 5 years with the presence of strong products in the pipeline. However, there are few restraints for the growth of the market like high development cost being the major one. And also, stringent regulatory guidelines, long durations required for the research and development of antibodies, longer periods of clinical trials are some of the hurdles faced by the market.

Geographical Analysis: 
The global Monoclonal Antibodies are segmented based on the application of Liver, Breast, Blood, Brain, Hodgkins and Non-Hodgkins lymphoma, Colorectal, leukemia, and others. The market is also analyzed based on segmented by type of monoclonal antibodies as murine antibodies, chimeric and humanized antibodies and fully humanized antibodies. The market is also augmented by Conjugated Cancer therapies using Monoclonal Antibodies as Immunoliposome, Radioimmunotherapy, ADEPT, immunocytokines and others. The global market is also categorized based on the geographical region as North America, Europe, Asia-Pacific, Middle East & Africa and Latin America.

Key Players in this Market: 
The highly customizable nature of the monoclonal antibodies is attracting various organizations, research institutes, and multinational companies to use it as a tool to cure cancer. The major players in the Cancer Monoclonal Antibodies Market are Amgen, Genmab, glaxosmithkline, Bristol Myers Squibb, Roche, Eli Lilly, Immunogen, Novartis, Seattle Genetics and Spectrum Pharmaceuticals.

  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

  1. Market Segmentation

                5.1 By Application                                                                           

                                5.1.1 Liver                                                           

                                5.1.2 Breast                                                       

                                5.1.3 Brain                                                          

                                5.1.4 Blood                                                         

                                5.1.5 Hodgkins and Non-Hodgkins lymphoma                                                    

                                5.1.6 Colorectal                                                

                                5.1.7 Leukaemia                                                              

                                5.1.8 Others                                                      

                5.2 By Type                                                                        

                                5.2.1 Murine Antibodies                                                              

                                5.2.2 Chimeric and Humanised Antibodies                                                           

                                5.2.3 Fully Humanized Antibodies                                                            

                5.3 Conjugate Cancer Therapies                                                                               

                                5.3.1 Immunoliposome                                                

                                5.3.2 Radioimmunotherapy                                                        

                                5.3.3 ADEPT                                                       

                                5.3.4 Immunocytokines                                                

                                5.3.5 Others                                                      

  1. Geographical Analysis

                6.1 North America                                                                          

                                6.1.1 Introduction                                                           

                                6.1.2 United States                                                         

                                6.1.3 Canada                                                     

                6.2 Europe                                                                         

                                6.2.1 Introduction                                                           

                                6.2.2 U.K                                                             

                                6.2.3 Spain                                                         

                                6.2.4 Germany                                                 

                                6.2.5 Italy                                                            

                                6.2.6 France                                                       

                6.3 Asia-Pacific                                                                 

                                6.3.1 Introduction                                                           

                                6.3.2 China                                                         

                                6.3.3 India                                                          

                                6.3.4 Japan                                                         

                                6.3.5 South Korea                                                           

                6.4 Latin America                                                                             

                                6.4.1 Introduction                                                           

                                6.4.2 Brazil                                                          

                                6.4.3 Mexico                                                     

                                6.4.4 Rest of Latin America                                                          

                6.5 Middle East & Africa                                                                               

                                6.5.1 Introduction                                                           

                                6.5.2 Middle-East                                                            

                                6.5.3 Africa                                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

  1. Market Leaders' Analysis

                8.1 Roche                                                           

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Amgen                                                         

                8.3 Genmab                                                      

                8.4 Glaxosmithkline                                                       

                8.5 Bristol Meyer Squibb                                                              

                8.6 Eli Lilly                                                           

                8.7 Immunogen                                                               

                8.8 Novartis                                                       

                8.9 Seattle Genetics                                                       

                8.10 Spectrum Pharmaceuticals                                                

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

     Appendix                                                                                           

  1. List of Tables
  2. List of Figures
  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Cancer Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Million )
  2. Global Cancer Monoclonal Antibodies Market By Application, From 2018-2023 ( USD Million )
  3. Global Liver Market By Region, From 2018-2023 ( USD Million )
  4. Global Breast Market By Region, From 2018-2023 ( USD Million )
  5. Global Brain Market By Region, From 2018-2023 ( USD Million )
  6. Global Blood Market By Region, From 2018-2023 ( USD Million )
  7. Global Hodgkins and Non-Hodgkins lymphoma Market By Region, From 2018-2023 ( USD Million )
  8. Global Colorectal Market By Region, From 2018-2023 ( USD Million )
  9. Global Leukaemia Market By Region, From 2018-2023 ( USD Million )
  10. Global Others Market By Region, From 2018-2023 ( USD Million )
  11. Global Cancer Monoclonal Antibodies Market By Type, From 2018-2023 ( USD Million )
  12. Global Murine Antibodies Market By Region, From 2018-2023 ( USD Million )
  13. Global Chimeric and Humanised Antibodies Market By Region, From 2018-2023 ( USD Million )
  14. Global Fully Humanized Antibodies Market By Region, From 2018-2023 ( USD Million )
  15. Global Cancer Monoclonal Antibodies Market By Conjugate Cancer Therapies, From 2018-2023 ( USD Million )
  16. Global Immunoliposome Market By Region, From 2018-2023 ( USD Million )
  17. Global Radioimmunotherapy Market By Region, From 2018-2023 ( USD Million )
  18. Global ADEPT Market By Region, From 2018-2023 ( USD Million )
  19. Global Immunocytokines Market By Region, From 2018-2023 ( USD Million )
  20. Global Others Market By Region, From 2018-2023 ( USD Million )
  21. North America Cancer Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Million )
  22. North America Cancer Monoclonal Antibodies Market By Application, From 2018-2023 ( USD Million )
  23. North America Liver Market By Region, From 2018-2023 ( USD Million )
  24. North America Breast Market By Region, From 2018-2023 ( USD Million )
  25. North America Brain Market By Region, From 2018-2023 ( USD Million )
  26. North America Blood Market By Region, From 2018-2023 ( USD Million )
  27. North America Hodgkins and Non-Hodgkins lymphoma Market By Region, From 2018-2023 ( USD Million )
  28. North America Colorectal Market By Region, From 2018-2023 ( USD Million )
  29. North America Leukaemia Market By Region, From 2018-2023 ( USD Million )
  30. North America Others Market By Region, From 2018-2023 ( USD Million )
  31. North America Cancer Monoclonal Antibodies Market By Type, From 2018-2023 ( USD Million )
  32. North America Murine Antibodies Market By Region, From 2018-2023 ( USD Million )
  33. North America Chimeric and Humanised Antibodies Market By Region, From 2018-2023 ( USD Million )
  34. North America Fully Humanized Antibodies Market By Region, From 2018-2023 ( USD Million )
  35. North America Cancer Monoclonal Antibodies Market By Conjugate Cancer Therapies, From 2018-2023 ( USD Million )
  36. North America Immunoliposome Market By Region, From 2018-2023 ( USD Million )
  37. North America Radioimmunotherapy Market By Region, From 2018-2023 ( USD Million )
  38. North America ADEPT Market By Region, From 2018-2023 ( USD Million )
  39. North America Immunocytokines Market By Region, From 2018-2023 ( USD Million )
  40. North America Others Market By Region, From 2018-2023 ( USD Million )
  41. Europe Cancer Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Million )
  42. Europe Cancer Monoclonal Antibodies Market By Application, From 2018-2023 ( USD Million )
  43. Europe Liver Market By Region, From 2018-2023 ( USD Million )
  44. Europe Breast Market By Region, From 2018-2023 ( USD Million )
  45. Europe Brain Market By Region, From 2018-2023 ( USD Million )
  46. Europe Blood Market By Region, From 2018-2023 ( USD Million )
  47. Europe Hodgkins and Non-Hodgkins lymphoma Market By Region, From 2018-2023 ( USD Million )
  48. Europe Colorectal Market By Region, From 2018-2023 ( USD Million )
  49. Europe Leukaemia Market By Region, From 2018-2023 ( USD Million )
  50. Europe Others Market By Region, From 2018-2023 ( USD Million )
  51. Europe Cancer Monoclonal Antibodies Market By Type, From 2018-2023 ( USD Million )
  52. Europe Murine Antibodies Market By Region, From 2018-2023 ( USD Million )
  53. Europe Chimeric and Humanised Antibodies Market By Region, From 2018-2023 ( USD Million )
  54. Europe Fully Humanized Antibodies Market By Region, From 2018-2023 ( USD Million )
  55. Europe Cancer Monoclonal Antibodies Market By Conjugate Cancer Therapies, From 2018-2023 ( USD Million )
  56. Europe Immunoliposome Market By Region, From 2018-2023 ( USD Million )
  57. Europe Radioimmunotherapy Market By Region, From 2018-2023 ( USD Million )
  58. Europe ADEPT Market By Region, From 2018-2023 ( USD Million )
  59. Europe Immunocytokines Market By Region, From 2018-2023 ( USD Million )
  60. Europe Others Market By Region, From 2018-2023 ( USD Million )
  61. Asia-Pacific Cancer Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Million )
  62. Asia-Pacific Cancer Monoclonal Antibodies Market By Application, From 2018-2023 ( USD Million )
  63. Asia-Pacific Liver Market By Region, From 2018-2023 ( USD Million )
  64. Asia-Pacific Breast Market By Region, From 2018-2023 ( USD Million )
  65. Asia-Pacific Brain Market By Region, From 2018-2023 ( USD Million )
  66. Asia-Pacific Blood Market By Region, From 2018-2023 ( USD Million )
  67. Asia-Pacific Hodgkins and Non-Hodgkins lymphoma Market By Region, From 2018-2023 ( USD Million )
  68. Asia-Pacific Colorectal Market By Region, From 2018-2023 ( USD Million )
  69. Asia-Pacific Leukaemia Market By Region, From 2018-2023 ( USD Million )
  70. Asia-Pacific Others Market By Region, From 2018-2023 ( USD Million )
  71. Asia-Pacific Cancer Monoclonal Antibodies Market By Type, From 2018-2023 ( USD Million )
  72. Asia-Pacific Murine Antibodies Market By Region, From 2018-2023 ( USD Million )
  73. Asia-Pacific Chimeric and Humanised Antibodies Market By Region, From 2018-2023 ( USD Million )
  74. Asia-Pacific Fully Humanized Antibodies Market By Region, From 2018-2023 ( USD Million )
  75. Asia-Pacific Cancer Monoclonal Antibodies Market By Conjugate Cancer Therapies, From 2018-2023 ( USD Million )
  76. Asia-Pacific Immunoliposome Market By Region, From 2018-2023 ( USD Million )
  77. Asia-Pacific Radioimmunotherapy Market By Region, From 2018-2023 ( USD Million )
  78. Asia-Pacific ADEPT Market By Region, From 2018-2023 ( USD Million )
  79. Asia-Pacific Immunocytokines Market By Region, From 2018-2023 ( USD Million )
  80. Asia-Pacific Others Market By Region, From 2018-2023 ( USD Million )
  81. Latin America Cancer Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Million )
  82. Latin America Cancer Monoclonal Antibodies Market By Application, From 2018-2023 ( USD Million )
  83. Latin America Liver Market By Region, From 2018-2023 ( USD Million )
  84. Latin America Breast Market By Region, From 2018-2023 ( USD Million )
  85. Latin America Brain Market By Region, From 2018-2023 ( USD Million )
  86. Latin America Blood Market By Region, From 2018-2023 ( USD Million )
  87. Latin America Hodgkins and Non-Hodgkins lymphoma Market By Region, From 2018-2023 ( USD Million )
  88. Latin America Colorectal Market By Region, From 2018-2023 ( USD Million )
  89. Latin America Leukaemia Market By Region, From 2018-2023 ( USD Million )
  90. Latin America Others Market By Region, From 2018-2023 ( USD Million )
  91. Latin America Cancer Monoclonal Antibodies Market By Type, From 2018-2023 ( USD Million )
  92. Latin America Murine Antibodies Market By Region, From 2018-2023 ( USD Million )
  93. Latin America Chimeric and Humanised Antibodies Market By Region, From 2018-2023 ( USD Million )
  94. Latin America Fully Humanized Antibodies Market By Region, From 2018-2023 ( USD Million )
  95. Latin America Cancer Monoclonal Antibodies Market By Conjugate Cancer Therapies, From 2018-2023 ( USD Million )
  96. Latin America Immunoliposome Market By Region, From 2018-2023 ( USD Million )
  97. Latin America Radioimmunotherapy Market By Region, From 2018-2023 ( USD Million )
  98. Latin America ADEPT Market By Region, From 2018-2023 ( USD Million )
  99. Latin America Immunocytokines Market By Region, From 2018-2023 ( USD Million )
  100. Latin America Others Market By Region, From 2018-2023 ( USD Million )
  101. Middle East & Africa Cancer Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Million )
  102. Middle East & Africa Cancer Monoclonal Antibodies Market By Application, From 2018-2023 ( USD Million )
  103. Middle East & Africa Liver Market By Region, From 2018-2023 ( USD Million )
  104. Middle East & Africa Breast Market By Region, From 2018-2023 ( USD Million )
  105. Middle East & Africa Brain Market By Region, From 2018-2023 ( USD Million )
  106. Middle East & Africa Blood Market By Region, From 2018-2023 ( USD Million )
  107. Middle East & Africa Hodgkins and Non-Hodgkins lymphoma Market By Region, From 2018-2023 ( USD Million )
  108. Middle East & Africa Colorectal Market By Region, From 2018-2023 ( USD Million )
  109. Middle East & Africa Leukaemia Market By Region, From 2018-2023 ( USD Million )
  110. Middle East & Africa Others Market By Region, From 2018-2023 ( USD Million )
  111. Middle East & Africa Cancer Monoclonal Antibodies Market By Type, From 2018-2023 ( USD Million )
  112. Middle East & Africa Murine Antibodies Market By Region, From 2018-2023 ( USD Million )
  113. Middle East & Africa Chimeric and Humanised Antibodies Market By Region, From 2018-2023 ( USD Million )
  114. Middle East & Africa Fully Humanized Antibodies Market By Region, From 2018-2023 ( USD Million )
  115. Middle East & Africa Cancer Monoclonal Antibodies Market By Conjugate Cancer Therapies, From 2018-2023 ( USD Million )
  116. Middle East & Africa Immunoliposome Market By Region, From 2018-2023 ( USD Million )
  117. Middle East & Africa Radioimmunotherapy Market By Region, From 2018-2023 ( USD Million )
  118. Middle East & Africa ADEPT Market By Region, From 2018-2023 ( USD Million )
  119. Middle East & Africa Immunocytokines Market By Region, From 2018-2023 ( USD Million )
  120. Middle East & Africa Others Market By Region, From 2018-2023 ( USD Million )
Middle East And Africa Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth...
Asia Pacific Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, A...
Europe Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, ...
Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts ...
Middle East And Africa Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) A...
Latin America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Asia Pacific Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Regi...
Europe Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - I...
North America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - Industry...
Pharmaceutical Gelatin Market By Function (stabilizers, Thickeners, Gelling Agents And Others) , By Source( Pig Skin, Bovine Hides, Bones And Others), By Application ( Hard Capsules, Soft Capsules, Microencapsulatio...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.